Key result
Chromosomal abnormalities in congenital cardiovascular malformations linked to slower annual mortality declines vs non-chromosomal cases.
Why the study?
Congenital cardiovascular malformations affect 0.5–0.7% of live births, motivating an assessment of US mortality trends in patients with and without chromosomal abnormalities from 1999 to 2020.
Observational (n=117,837)
From 1999 to 2020 in the US, mortality related to congenital cardiovascular malformations declined among patients without chromosomal abnormalities but remained largely unchanged in those with chromosomal abnormalities, with notable demographic and geographic disparities.
Answers are grounded in this paper and cite their sources.
Persistent mortality gaps in chromosomal congenital heart cases may necessitate improved specialty access; leaves open causal mechanisms and intervention trials.
Background Congenital cardiovascular malformations (CVMs) affect 0.5–0.7% of live births. We assessed mortality trends in patients with CVMs with and without chromosomal abnormalities (CAs) from 1999–2020. Methods CDC WONDER provided crude and age-adjusted mortality rates (AAMRs) per 1,000,000 population, stratified by year, sex, race, age, and region. Joinpoint regression assessed average annual percentage changes (AAPCs). Results Among 117,837 CVM-related deaths, 12,049 (10%) involved CAs. Mortality declined among patients without CAs (AAPC −1.9%) but remained largely unchanged among those with CAs (AAPC −1.0%, p<0.001). Females with CAs had higher AAMRs than males (2.21 vs 1.59). Hispanic/Latino patients had higher AAMRs than non-Hispanics (1.90 vs 1.85). Infants with CAs had the highest AAMR (100.64). Mortality was higher in rural areas, the Midwest, and states with fewer accredited centers. Conclusion CVM mortality declined without CAs but remained unchanged with CAs.
No takes yet. Share an insight, caveat, or question.
Rehman et al. (2026) conducted an observational in Congenital cardiovascular malformations (n=117,837). Chromosomal abnormalities vs. Patients without chromosomal abnormalities was evaluated on Average annual percentage change (AAPC) in age-adjusted mortality rates (AAPC -1.0% vs -1.9%, p=<0.001). Chromosomal abnormalities in patients with congenital cardiovascular malformations were associated with largely unchanged mortality from 1999–2020 vs those without.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: